Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Exelixis
Exelixis
Biotech Busts And Breakthroughs In December
Forbes
Mon, 01/3/11 - 02:44 pm
biotech
InterMune
Orexigen
Exelixis
Dynavax
Sangamo BioSciences
Pain Therapeutics
Abiomed
Keryx
Geron
Clinical Data
3 Ways to Play Biotech With Options
Motley Fool
Tue, 12/14/10 - 09:47 pm
biotech
options
Avanir
Orexigen
Exelixis
Momenta
Changing the Perception of the Biotech One-Trick Pony
Seeking Alpha
Wed, 12/8/10 - 09:59 am
Alexion
Dendreon
ImClone
Exelixis
ONYX Pharmaceuticals
Biotech Calendar: Key Dates for December
TheStreet.com
Tue, 11/30/10 - 09:20 am
Delcath
Arena Pharmaceuticals
RXi Pharmaceuticals
Cell Therapeutics
Amgen
Incyte
Celgene
Corcept Therapeutics
Affymax
Targacept
Exelixis
Orexigen
ONYX Pharmaceuticals
Seattle Genetics
MannKind
Alimera
AstraZeneca
Human Genome Sciences
Promising Data Puts Exelixis Back on Track
Seeking Alpha
Sun, 11/28/10 - 11:30 am
Exelixis
XL184
cancer
Exelixis: Up 32% With Room to Run
Motley Fool
Sat, 11/20/10 - 12:08 pm
XL184
ovarian cancer
prostate cancer
Exelixis
Bristol-Myers Squibb
Exelixis Deepens Profitable Ties to BMS
Seeking Alpha
Mon, 10/18/10 - 09:41 am
Bristol-Myers Squibb
Exelixis
diabetes
partnerships
Exelixis, Bristol-Myers in $565M deal
Bizjournals.com
Mon, 10/11/10 - 10:50 am
Exelixis
Bristol-Myers Squibb
Volume Hunter: Diet Stocks Lift Biotech
Yahoo/IndieResearch
Thu, 09/2/10 - 04:01 pm
diet drugs
biotech
Arena Pharmaceuticals
Dendreon
Provenge
Exelixis
Vivus
Orexigen
Takeda
Contrave
Martek
Exelixis gains; drug indexes split in early trade
Marketwatch
Thu, 08/26/10 - 10:35 am
Exelixis
drug stocks
Exelixis cuts Q2 loss to $22.6M
Bizjournals.com
Fri, 08/6/10 - 07:25 am
earnings
Exelixis
3 Development-Stage Drugmakers Worth Watching
Motley Fool
Sun, 08/1/10 - 02:29 pm
InterMune
Medivation
Exelixis
Bristol-Myers Squibb
GSK
Roche
Seattle Genetics
Regeneron
Jury Still Out on Exelixis's Long Term Potential
Seeking Alpha
Mon, 07/26/10 - 11:00 am
Sanofi
Novartis
GSK
Exelixis
cancer
Bristol-Myers Squibb
Arqule
June's Biotech Busts And Breakthroughs
Forbes
Sat, 07/3/10 - 10:00 am
biotech
companies
Celgene
Neurocrine
Abbott Laboratories
Dendreon
Exelixis
Affymax
Amgen
Report: Exelixis' Scangos named Biogen CEO
Bizjournals.com
Wed, 06/30/10 - 03:35 pm
Biogen Idec
Pharma CEOs
Exelixis
George Scangos
Exelixis: Finding Opportunity in a Bottomed Stock
Seeking Alpha
Mon, 06/28/10 - 02:58 pm
Exelixis
Bristol-Myers Squibb
cancer
Bristol-Myers Dumps Exelixis Drug
Motley Fool
Mon, 06/21/10 - 07:27 pm
Bristol-Myers Squibb
Exelixis
cancer
partnerships
Exelixis regains rights to a cancer drug from BMY
Marketwatch
Mon, 06/21/10 - 09:19 am
Exelixis
Bristol-Myers Squibb
cancer
Exelixis Announces June 21 Webcast of Conference Call Update on Development Collaboration with Bristol-Myers Squibb Company for XL184
Yahoo/BusinessWire
Sat, 06/19/10 - 11:19 am
Exelixis
Bristol-Myers Squibb
XL184
investors
Exelixis Pharma Narrows Loss
Yahoo/Zacks.com
Mon, 05/17/10 - 01:35 pm
Exelixis
earnings
Bristol-Myers Squibb
Sanofi
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
next ›
last »